Evaluating muscle loss in menopausal women with and without hormone therapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to assess the prevalence of sarcopenia in menopausal women, comparing those receiving hormone replacement therapy (HRT) to those not receiving it, as well as to pre-menopausal women. Participants will be divided into three groups based on their menopausal status and hormone therapy usage. The study will utilize various assessment methods, including the SARC-F questionnaire, handgrip test, chair stand test, and bioimpedance analysis, to evaluate muscle strength and mass. Data will be collected through health records and physical examinations during outpatient visits.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients attending the O.U. of Gynecology and Pathophysiology of Human Reproduction in menopause who take or do not take hormone replacement therapy at the time of visit as normal clinical practice and women in pre-menopause.

Patients for whom informed consent has been obtained.

Exclusion Criteria:

* no exclusion criteria are provided

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria Bologna
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Maria C Meriggiola — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Giulia Gava, MD
• Email: gava.giulia@hotmail.it
• Phone: 0512143716

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sarcopenia in Patients After Cardiac Surgery

  This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

• Bone marrow mesenchymal stem cell injection for sarcopenia

  This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.

  Recruiting Phase 1/2 GuangZhou Cellgenes Biotechnology Co., Ltd. · Guangzhou · NCT07865676

• GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes

  This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.

  Recruiting Istanbul Saglik Bilimleri University · Istanbul, Kucukcekmece · NCT07858864

• Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis

  We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.

  Recruiting Marmara University · Istanbul, Istanbul · NCT07855419

• Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients

  This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.

  Recruiting Zhangzhou Municipal Hospital · Zhangzhou, Fujian · NCT07836088

• Lower-limb rehabilitation robot training with nutrition education for sarcopenia

  In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.

  Recruiting Taipei Medical University Hospital · Taipei, Taipei City · NCT07830472

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.